Group 1 - The U.S. government will impose a 100% tariff on all imported brand-name or patented drugs starting October 1, 2023, with exemptions for companies building pharmaceutical plants in the U.S. [1] - In 2023, the U.S. imported $203 billion worth of drugs, with 73% coming from Europe, primarily Ireland, Germany, and Switzerland [1] - A report commissioned by the U.S. pharmaceutical industry indicates that a 25% tariff on drug imports could increase U.S. drug costs by nearly $51 billion annually, potentially raising drug prices by up to 12.9% for consumers [1] Group 2 - The U.S. will also impose a 25% tariff on all imported heavy trucks to protect domestic manufacturers from unfair external competition [4] - The five largest sources of imported heavy trucks are Mexico, Canada, Japan, Germany, and Finland, which are considered allies and pose minimal threats to U.S. national security [4] - Tariffs of 50% will be applied to kitchen cabinets, bathroom sinks, and related building materials, while a 30% tariff will be imposed on imported upholstered furniture [4] Group 3 - The U.S. Treasury Secretary mentioned alternative options for potential legal challenges regarding tariff legitimacy, including the Trade Expansion Act of 1962, which allows the Commerce Department to investigate imports threatening national security [5] - The Commerce Department has previously initiated investigations under this act for various products, including automobiles, copper, steel, and aluminum [5] - A new investigation was launched on September 2, 2023, covering products such as industrial machinery and medical devices [5]
涉及药品、重卡、厨卫、家具,美国出台新一批高额关税措施
Sou Hu Cai Jing·2025-09-26 01:59